MediPharm Labs names new CEO
by CM Staff
David Pidduck brings more than 20 years of leadership experience to MediPharm.
BARRIE — MediPharm Labs Corp. has appointed Pharma and Med Tech executive David Pidduck as its new CEO and director of the company.
Pidduck replaces outgoing CEO and director Bryan Howcroft, who is stepping down for personal reasons.
MediPharm says David Pidduck brings more than 20 years of leadership experience to MediPharm, including serving as president and CEO of a Canadian pharmaceutical company, where he was also a member of the board of directors.
Over the course of his career, Pidduck has been involved in the commercialization of several products in both Canadian and international markets.
Pidduck has an MBA from Kellogg or Northwestern University and an honours bachelor of business administration from Wilfrid Laurier University.
“We are very pleased to welcome David Pidduck to MediPharm. The company continues to make progress building its sales pipeline both in Canada and internationally, driving toward consistent revenue growth and profitability. With a strong background in business development, strategy, and M&A within the Pharma and Med Tech sectors, David is the right individual to lead the company through this formative period. On behalf of the board, I would like to sincerely thank Bryan for his contributions and wish him all the best,” said Chris Taves, chairman of the board in a statement.
